8.1 Prescription Labeling Requirements & Expiration Dating

8.1 Prescription Labeling Requirements & Expiration Dating

Prescription labeling serves as the primary regulatory and clinical bridge between the dispensing pharmacy, the prescriber, and the patient. In the Commonwealth of Virginia, prescription container labeling is governed by both state statutory law (Code of Virginia § 54.1-3410) and the Virginia Board of Pharmacy regulations (18VAC110-20-330), layered with mandatory federal standards established by the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA).

A prescription label is not merely an informative sticker; under pharmacy law, it is a legally binding document. Omission of a required statutory element, inaccurate beyond-use dating, or failure to affix mandatory federal warnings renders the drug legally misbranded, subjecting both the dispensing pharmacist and the pharmacy permit holder to disciplinary sanctions and administrative penalties.

---

Mandatory Prescription Label Elements in Virginia

Under Virginia Code § 54.1-3410 and 18VAC110-20-330, every prescription container dispensed to an outpatient in Virginia must bear a clearly legible label containing the following ten (10) mandatory elements:

1. Pharmacy Name and Physical Address: The commercial name and physical street address of the dispensing pharmacy. In shared-service or central-fill arrangements, the label must clearly identify the primary dispensing pharmacy responsible for patient interaction.
2. Prescription Serial Number: The unique, sequential prescription tracking number (Rx number) assigned by the pharmacy dispensing system.
3. Dispensing Date: The exact date on which the prescription was initially filled or refilled. If the prescription is being refilled, the refill date must be indicated.
4. Patient Identification:
   • Human Patients: The patient's full legal name (first and last name).
   • Veterinary Patients: Under 18VAC110-20-330, if the medication is dispensed for an animal, the label must state the full legal name of the owner AND the specific animal species (e.g., "John Doe (Canine)" or "John Doe - Dog: Max"). Omitting the animal species or stating only the pet's name without the owner is an explicit regulatory violation.
5. Prescribing Practitioner Name: The full name of the authorized prescriber.
6. Directions for Use: Explicit, clear instructions for use as stated by the prescriber. Broad or ambiguous instructions such as "use as directed" or "take as needed" should not be placed on the label unless the prescriber has explicitly indicated that precise instructions were provided directly to the patient and documented in the pharmacy record.
7. Drug Product Identification & Strength:
   • Brand Name Dispensed: If a single-source or brand-name drug is dispensed, the proprietary/brand name and strength are listed.
   • Generic Drug Dispensed: If a generic drug product is dispensed, Virginia law strictly requires the established generic name AND the name of the manufacturer or distributor of the generic product (e.g., "Atorvastatin 20 mg (Teva)"). Listing the generic name alone without the manufacturer/distributor violates state labeling rules.
8. Quantity Dispensed: The metric quantity or exact number of dosage units dispensed (e.g., "30 Tablets" or "150 mL").
9. Number of Remaining Refills: The number of authorized refills remaining on the prescription, or an explicit statement such as "0 refills remaining" or "No Refills".
10. Expiration Date / Beyond-Use Date (BUD): The beyond-use date indicating when the medication should no longer be used by the patient.

Virginia Outpatient Prescription Label Elements Reference

---

Expiration Dating & Beyond-Use Dating (BUD) Mechanics

A critical distinction on the Virginia MPJE is the legal difference between the Manufacturer's Expiration Date and the Dispensed Beyond-Use Date (BUD).

Manufacturer Expiration Date vs. Dispensing Beyond-Use Date

• Manufacturer Expiration Date: Determined through rigorous commercial stability testing under United States Pharmacopeia (USP) standards and FDA Current Good Manufacturing Practices (cGMP). It represents the date until which the manufacturer guarantees the full potency, purity, and safety of the drug in its original, unopened container.
  • If the manufacturer's expiration date specifies only a month and a year (e.g., "Exp: 08/2027"), federal law interprets the expiration date as the final day of that month (August 31, 2027).
• Beyond-Use Date (BUD): The date calculated and placed on the prescription container by the dispensing pharmacy, beyond which the patient should not use the medication once it has been transferred from the manufacturer container into a dispensing vial.

The Virginia Beyond-Use Date Calculation Standard

Under 18VAC110-20-330, the beyond-use date placed on an outpatient prescription label cannot exceed the earlier of:

1. One (1) year from the date of dispensing; or
2. The manufacturer's expiration date on the stock container.

Virginia Outpatient BUD Decision Formula:
BUD = MINIMUM ( [Dispensing Date + 1 Year], [Manufacturer Stock Bottle Expiration Date] )

Practical Calculation Examples:

• Scenario A: A pharmacist dispenses amlodipine 5 mg on September 4, 2026. The manufacturer bottle expires in November 2028. One year from dispensing is September 4, 2027. Since September 4, 2027 is earlier than November 30, 2028, the label BUD is September 4, 2027.
• Scenario B: A pharmacist dispenses sertraline 50 mg on September 4, 2026. The manufacturer bottle expires in February 2027 (February 28, 2027). One year from dispensing is September 4, 2027. Because the manufacturer bottle expires earlier (February 28, 2027), the label BUD cannot be one year; it MUST be February 28, 2027.

BUD for Reconstituted Powders and Specialized Dosage Forms

For oral suspensions reconstituted from dry powders, the beyond-use date is dictated by manufacturer stability guidelines approved by the FDA rather than the default 1-year rule:

• Amoxicillin oral suspension: 14 days when refrigerated (stable at room temperature, but refrigeration preferred for taste).
• Amoxicillin/clavulanate (Augmentin) oral suspension: 10 days refrigerated (MUST be refrigerated; degrades rapidly at room temperature).
• Cefdinir (Omnicef) oral suspension: 10 days stored at room temperature (do NOT refrigerate; refrigeration causes thickening and precipitation).
• Azithromycin (Zithromax) oral suspension: 10 days stored at room temperature (do not refrigerate).

---

Federal Auxiliary Warning Statements

In addition to the core label elements required by Virginia statute, specific federal regulations mandate cautionary auxiliary statements on outpatient prescription containers.

1. The Federal Controlled Substance Transfer Warning (21 CFR § 290.5)

Under federal regulation 21 CFR § 290.5, the dispensing container of any controlled substance in Schedule II, Schedule III, or Schedule IV must bear an explicit cautionary statement:

"CAUTION: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed."

Critical Exam Distinctions:

• Mandatory Schedules: Schedules II, III, and IV ONLY.
• Exempt Schedules:
  • Schedule V: Federal law does NOT require the transfer warning on Schedule V controlled substances (e.g., pregabalin, lacosamide, promethazine with codeine).
  • Schedule VI: Virginia's unique Schedule VI legend drugs are NOT subject to this federal controlled substance transfer warning.
• Investigational Exemption: The warning is not required when controlled substances are dispensed in blinded, double-blind clinical investigational research studies.

2. FDA MedWatch Side-Effects Notification (21 CFR § 209.11)

Under federal Food and Drug Administration regulations (21 CFR Part 209), every pharmacy dispensing an outpatient prescription must distribute the standardized FDA side-effects warning:

"Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088."

Federal law permits the pharmacy to fulfill this requirement through any one of five (5) approved mechanisms:

1. On a preprinted sticker attached directly to the prescription vial;
2. Preprinted directly on the prescription vial cap;
3. On a separate sheet of paper delivered with the medication;
4. Included in consumer medication information (CMI) / patient education leaflets printed by the pharmacy system; or
5. Printed within an FDA-approved Medication Guide distributed with the medication.

3. Clinical Auxiliary Warning Labels (Standard of Care)

While state and federal laws codify specific mandatory text, pharmacy standards of care require auxiliary labels to ensure therapeutic efficacy and prevent severe adverse reactions:

• "Refrigerate — Do Not Freeze" (36°F to 46°F / 2°C to 8°C): Required for biologicals, insulins, vaccines, and reconstituted suspensions requiring cold storage.
• "Shake Well Before Using": Mandatory for all suspensions to ensure homogeneous drug distribution and uniform dosing.
• "Take With Food" or "Take on an Empty Stomach": Required where food significantly alters bioavailability or gastric tolerance (e.g., NSAIDs with food; levothyroxine on an empty stomach with water 30–60 minutes before breakfast).
• "Do Not Drink Alcoholic Beverages": Crucial for CNS depressants, metronidazole (disulfiram-like reaction), and sedatives.
• "Finish All Medication Unless Otherwise Directed": Applied to systemic anti-infective regimens to prevent antimicrobial resistance.

---

High-Yield Virginia MPJE Traps & Regulatory Highlights

Common Prescription Labeling Violations on the Virginia MPJE:
├── Generic Substitution: Omitting manufacturer/distributor name (e.g., writing only "Simvastatin 20mg")
├── Veterinary Prescriptions: Stating only the pet's name without owner's legal name AND animal species
├── Beyond-Use Dating: Setting 1-year BUD when manufacturer bottle expires in less than 12 months
├── Transfer Warning Error: Applying the 21 CFR § 290.5 warning to Schedule V or Schedule VI medications
└── Ambiguous Directions: Entering "Use As Directed" without prescriber clarification in the record